TOTAL: $152.951M

Company (Location)

Type Of Financing

Number Of Shares, Units Or Warrants (M)

Amount Raised (M)

Investors; Placement Agents; Details (Date)

Agenus Inc. (Lexington, Mass.)

Private placement of common stock

13.73S

$7

Agenus raised $7M by placing 13.73M shares at 51 cents each (8/15)

Evolva Holding SA (Reinach, Switzerland)

Standby equity distribution agreement

N/A

CHF0.5 ($0.635)

Evolva entered a SEDA with YA Global Master SPV Ltd., which has committed to provide up to CHF30M ($38.1M) in equity financing over 36 months, with an initial advance of CHF500,000 in exchange for Evolva shares (8/16)

Fibrocell Science Inc. (Exton, Pa.)

Private placement

41.2S

$22.8

Fibrocell raised $22.8M through a placement of 41.4M shares for 55 cents apiece; Rodman & Renshaw LLC and Gleacher & Co. Sec. Inc. acted as joint lead placement agents, with John Carris Investments LLC acting as co-placement agent (8/4)

Furiex Pharmaceuticals Inc. (Morrisville, N.C.)

Loan

N/A

$15

Furiex secured a $15M loan from MidCap Financial and Silicon Valley Bank (8/22)

Genfit SA (Lille, France)

Standby equity distribution agreement

N/A

(up to $7.2M)

Genfit secured a standby equity distribution agreement with YA Global Master SPV Ltd. in which it can draw down up to $7.2M over two years (8/25)

Lipoxen plc (London)

Investment and private placement

110.6S; 1.5S

£12.8 ($20.9); £1.6 ($2.62)

Lipoxen raised $20.9M through an investment from SynBio LLC, and it privately placed 1 .5M shares with Serum Institute to raise an additional $2.62M (8/8)

Lorus Therapeutics Inc. (Toronto)

Private placement of units

5.5U

C$2.2 ($2.2)

Lorus completed an offering of 5.5M units – each comprising one common share and one common share purchase warrant – priced at C40 cents apiece, for gross proceeds of $2.2M (8/16)

NeurogesX Inc. (San Mateo, Calif.)

Loan

N/A

$20

NeurogesX received a loan from Hercules Technology Growth Capital Inc. (8/10)

NuPathe Inc. (Conshohocken, Pa.)

Common stock purchase agreement

0.071S

$0.5

NuPathe raised $500,000 by offering 70,721 shares for $7.07 apiece (8/4)

PharmaGap Inc. (Ottawa, Ont.)

Private placement of units

5.5U

$0.496

PharmaGap raised $496,405 through the offering of 5.5M units, with each unit containing one common share and one warrant to purchase a common share at 14 cents with a two-year warrant term (8/5)

Somaxon Pharmaceuticals Inc. (San Diego)

Term loan agreement

N/A

$15

Somaxon received $15M through a term loan from Oxford Finance Corp. and Silicon Valley Bank (8/4)

Vivus Inc. (Mountain View, Calif.)

Registered direct offering

6.9S

$45.8

Vivus priced the offering of 6.9M shares at $6.65 each for gross proceeds of $45.8M (8/24)

Notes:

This chart does not include real estate or manufacturing plant financings, or debt deals done to replace existing debt. Loan money is included in the total only when it is drawn down, if disclosed.

** Denotes the date the item ran in BioWorld International. Currency conversions are based on exchange rates at the time of the deal.

The date indicated refers to the BioWorld Today issue in which the news item can be found.

N/A = Not applicable; ND = Not disclosed.